Western General Hospital, NHS Lothian, Edinburgh, UK.
Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow, UK.
Int J Clin Pharm. 2024 Dec;46(6):1445-1452. doi: 10.1007/s11096-024-01789-9. Epub 2024 Aug 7.
With hospital electronic prescribing and medicines administration (HEPMA) systems now in widespread use across hospital inpatient clinical services, work is underway to measure the benefits of HEPMA on healthcare systems and patient care. HEPMA functionality enables users to prescribe medicines by 'bundle' or 'protocol'. Although it is assumed that this is a significant system benefit, there are few qualitative studies supporting this conclusion.
To explore the impact of an electronic anticipatory care medicines protocol on junior doctor perceptions of their confidence and competence to prescribe opioids and midazolam for patients at the end of life.
Between May and August 2022, one-to-one semi-structured interviews were conducted at a 570-bed District General Hospital with junior doctors who had experience of prescribing on both HEPMA and paper-based systems. Audio recordings of the interviews were transcribed verbatim and underwent thematic analysis.
Ten junior doctors participated (median age 23 years). Analysis generated five main themes that described perceptions and attitudes towards confidence and competence. These were prescribing safety benefits; information technology infrastructure, interoperability and system design concerns; clinical knowledge and training needs; cultural and social factors and risks of automation in prescribing.
This study suggests that junior doctors experienced an overall increase in their confidence and perceived competence to prescribe anticipatory medicines post-implementation of a HEPMA protocol. Further studies are required to detail the impact of HEPMA/CPOE protocols on clinical practice.
随着医院电子处方和药品管理(HEPMA)系统在医院住院临床服务中广泛应用,目前正在努力衡量 HEPMA 对医疗系统和患者护理的益处。HEPMA 功能使用户能够通过“捆绑”或“协议”开处方。尽管人们认为这是一个重要的系统优势,但很少有定性研究支持这一结论。
探讨电子预期治疗药物方案对初级医生的影响,即他们对在生命末期为患者开阿片类药物和咪达唑仑的信心和能力的认知。
在 2022 年 5 月至 8 月期间,在一家拥有 570 张床位的地区综合医院,对在 HEPMA 和基于纸张的系统上都有开处方经验的初级医生进行了一对一的半结构化访谈。访谈的音频记录被逐字转录,并进行了主题分析。
10 名初级医生参与了研究(中位年龄 23 岁)。分析产生了五个主要主题,描述了对信心和能力的看法和态度。这些主题包括:处方安全效益;信息技术基础设施、互操作性和系统设计问题;临床知识和培训需求;文化和社会因素以及处方自动化风险。
本研究表明,初级医生在实施 HEPMA 方案后,整体上对预期药物的开处方信心和感知能力有所提高。需要进一步研究详细了解 HEPMA/CPOE 方案对临床实践的影响。